Must reads

• A December 2, 2014 Reuters article reported that "Biogen Idec Inc's research chief on Tuesday said the company is planning a late-stage trial of its experimental treatment for Alzheimer's disease after the drug cut brain plaque levels and significantly improved cognition in a small early-stage study." According to the article, "...the encouraging data was seen in a Phase 1b trial of its BIIB037 drug. It was tested in patients with mild symptoms of the progressive neurological disease, or in those who did not yet have apparent symptoms but had other possible signs of Alzheimer's." Also reported on by the Wall Street Journal, New York Times, Barron's, and others.
• A December 2, 2014 UT San Diego article reported that the San Diego county "Board of Supervisors unanimously voted to launch the Alzheimer’s Project, an ambitious initiative that unites the top minds from San Diego’s world-renowned research institutes to spur the discovery of a drug that has so far eluded the global scientific community." According to the article, "With a mix of enthusiasm, civic pride and a sense that they were embarking on a groundbreaking venture, speaker after speaker at the special meeting at the County Administration Building Tuesday said the Alzheimer’s Project would put a cure within reach — and that it may already exist in our midst."